Overnight Market report, page-2266

I think the BoD completely understand the predicament and I think their strategy has been to CR when the SP has not been ideal so they can advance trials/results without looking over their shoulders and worrying about being picked off by a low ball play.

I don't think they need to say it out loud to us.

I think this is the gauntlet that has to be run, particularly when you have a blockbuster technology that challenges vested interests.

The stellar (not an exaggeration imo) news this week, building on another year at major conferences. The value is becoming irrepressible. Marc's words being something like this is the best you could have wished for.

Imagine how much better everything is if you get NSCLC and can have this therapy, live longer, avoid chemo side affects ... imagine how much better that is for you and your family and friends. This is a stellar result. Compelling and now its looking very possible.

Bring it on.

QQ